SUMMARY
KATAYAMA, ET AL (AMI). [1] [2] [3] [4] An AMI occurs as a consequence of acute thrombosis following rupture of a vulnerable atherosclerotic plaque. 5) Inflammation is thought to be a trigger for plaque rupture. 6) In several studies, elevated levels of inflammatory reactants have been associated with an increased risk of subsequent cardiovascular events in patients with AMI. [7] [8] [9] Some previous studies have demonstrated that CRP, an acute phase representative protein, is associated with various complications including cardiac events, [7] [8] [9] and left ventricular dysfunction [10] [11] [12] [13] in AMI. When in vivo inflammation occurs, synthesis of serum amyloid A protein (SAA) as well as CRP in the liver is accelerated by inflammatory cytokines. Serum amyloid A protein, also an important acute phase inflammatory protein, has an expanded dynamic range with different kinetics compared with CRP and is reported to be a more sensitive indicator of inflammation in some noncardiovascular inflammatory conditions. 14) In other words, the kinetics of SAA are similar to those of CRP. For this reason, some reports have stated that the value of SAA reflects the severity of AMI. 15, 16) The relationship between the significance of the value of SAA in acute phase AMI and left ventricular systolic function, however, is still uncertain.
Therefore, the aim of this study was to investigate the relationship between plasma levels of SAA and left ventricular systolic function in patients with AMI.
METHODS
Patient population: A total of 486 patients (69 ± 12 years, 335 males, 151 females) were admitted to our hospital with acute myocardial infarction (AMI) within 12 hours of onset between August 1999 and January 2006. The study protocol and blood sampling of CRP and SAA were approved by the hospital ethics committee, and informed consent was obtained from each patient and/or their family by an investigator before entry into the study. A diagnosis of AMI was made on the basis of the following criteria: (1) complaint of chest pain; (2) electrocardiographic ST segment elevation of > 0.1 mV in two or more limb leads, or > 0.2 mV in two or more precordial leads, or presentation of left-bundle branch block; and (3) elevated peak-serum creatine kinase more than twice the upper limit of the patient's normal range. We excluded patients with renal failure on admission (serum creatinine level > 2.5 mg/dL), patients with old myocardial infarction, patients who reached the institution more than 12 hours after onset, and patients who died within 24 hours of onset (ie, when blood samples were taken). We excluded posterior infarctions from our evaluation because of the associated issue of inaccuracy. Furthermore, to avoid other variables that could influence the serum levels of SAA, we excluded patients with a history of recent surgery or trauma within the preceding 2 months, malignancy or liver cirrhosis, acute or On admission, blood samples were taken from all subjects while supine. Highly sensitive C-reactive protein (CRP), creatine kinase (CK), and troponin-T were all assessed from the same blood samples. CRP was serially determined every 24 hours for 3 days after admission, and CK was serially determined every 4 hours for 3 days after admission. Twenty-four hours after onset, blood samples were taken from all subjects while supine. Brain natriuretic peptide (BNP), atrial natriuretic peptide (ANP), renin, aldosterone, epinephrine, norepinephrine, and SAA were all assessed from the same blood samples. The assay of SAA was performed by BML (BioMedical Laboratories) Inc. using a latex agglutination nephelometric immunoassay (LA-NIA). Measurement of hemodynamics and cardiac function: Left ventriculograms were obtained in all subjects, from a single-plane with a right anterior deviation of 30 ° at the acute (soon after recanalization) and chronic (6 ± 1 months after onset) phases to evaluate the left-ventricular ejection fraction (LVEF) and left-ventricular end-diastolic volume index (LVEDVI), using the area-length method, and to evaluate regional wall motion (RWM), using the center-line method.
17) The differences between the parameters at the 2 stages (chronic stage -acute stage) were expressed as delta-LVEF, delta-LVEDVI, and delta-RWM, respectively. We excluded posterior infarctions from our evaluation because of the associated issue of inaccuracy. We also evaluated left ventricular end-diastolic pressure (LVEDP) at 2 separate stages. We used the Rentrop classification to evaluate collateral circulation before recanalization, and the Thrombolysis In Myocardial Infarction (TIMI) classification to evaluate epicardial coronary flow. On admission, the Killip classification was used to assess the severity of the patient's condition. Statistical analysis: Values are expressed as the mean ± standard deviation (SD). All statistical tests were two-tailed, and a P value < 0.05 was considered statistically significant. Correlations between serial variables have been analyzed using linear regression and a rank-correlation test, and a P value < 0.05 in addition to an absolute coefficient of correlation value of > 0.4 was considered statistically significant.
RESULTS
The clinical characteristics and laboratory findings of all patients (n = 486) are summarized in Table I . The mean age was 69 and 69% were male. An anterior (22) 49 (10) 44 (9) 287 (59) 199 (41) 415 (85) Continuous values are expressed as the mean ± SD (%). Time elapsed indicates time from onset to reperfusion; angina within 24 hours, existence of preinfarction angina pectoris within 24 hours of onset; LAD, left anterior descending artery; and RCA, right coronary artery. myocardial infarction had occurred in 287 patients. In 71 patients, conventional plain old balloon angioplasty was sufficient, while the remaining 415 all required coronary stenting. Table II shows the laboratory findings. The mean values of SAA, hsCRP, and BNP exceeded their upper limits of the normal ranges 24 hours from onset. Table III shows left-ventricular function in the acute (soon after recanalization) and chronic (6 ± 1 months after onset) phases. The mean value of acute phase LVEF was 51%, chronic phase LVEF was 56%, and delta LVEF was 5%. 
Acute phase indicates soon after recanalization; Chronic phase, 6 ± 1 months after onset; LVEDVI, left-ventricular end-diastolic volume index; RWM, regional wall motion; LVEF, left-ventricular ejection fraction; delta LVEDVI, differences in LVEDVI between two phases; delta RWM, differences in RWM between two phases; and delta LVEF, differences in LVEF between two phases. Other abbreviations as in Table I . The correlations between hs-CRP, LVEF, peak-CK, and SAA values are shown in Table IV . Both hs-CRP and peak-CK showed significant correlations with SAA (hs-CRP: r = 0.69, P < 0.0001, peak-CK: r = 0.21, P = 0.0003). Furthermore, the level of SAA showed a significant negative correlation with both LVEF and RWM in the chronic phase (LVEF: r = -0.42, P = 0.001; RWM: r = -0.41, P = 0.007). Significant negative correlations between SAA and both chronic LVEF and RWM were observed (Figures 1 and 2) . However, there were no significant correlations between hs CRP and the 2 indicators (Figures 3 and 4) . The SAA concentration was also significantly and negatively correlated with the differences in LVEF between the 2 stages (delta-LVEF) (r = -0.43, P = 0.02).
DISCUSSION
Immediate reperfusion in an infarct-related artery is associated with a favorable outcome in the treatment of AMI. [18] [19] [20] Thus, primary coronary angioplasty is an initial treatment strategy for AMI patients in current medical practice. 21, 22) Today, the prognosis for AMI and the preservation of cardiac function have been dramatically improved by applying aggressive revascularization strategies following proper coronary care unit management. 21, 22) However, some patients still have a poor clinical course and poor cardiac function in spite of early recanalization therapy by PCI.
Current thinking suggests systemic inflammation is associated with ischemic heart diseases, including AMI. [1] [2] [3] [4] Previous studies have demonstrated that CRP, an acute phase representative protein, is associated with various complications, such as cardiac events [7] [8] [9] and left ventricular dysfunction [10] [11] [12] 23) in AMI. Like hs-CRP, SAA is synthesized in the liver in response to infection and inflammation. Accordingly, SAA is also a representative inflammatory reactant. We reported that acute phase plasma SAA concentrations after successful direct PCI in AMI patients were closely related to major adverse complications, including mortality. 16, 24, 25) However, the implications of the elevation of SAA, which is also an inflammatory reactant, in the acute phase of AMI on cardiac function is unknown. The present study demonstrated a significant association between the SAA level in the acute phase of AMI and left ventricular systolic function.
An AMI occurs as a consequence of acute thrombosis following rupture of a vulnerable atherosclerotic plaque. 5) Inflammation is thought to be a trigger for plaque rupture.
6) It has been reported that plasma SAA concentrations become elevated from several hours to a few days after the onset of AMI, 15) and that the SAA concentration in AMI patients reaches its peak value about 24 hours after onset. 15) We thought the peak value of SAA was the most accurate indicator of the severity of AMI, which is why we took blood samples 24 hours after onset.
In our study, despite the fact that patients underwent immediate revascularization by direct percutaneous coronary intervention upon the onset of an AMI, within about 12 hours, the left ventricular systolic function in the chronic phase was damaged in correlation with the value of SAA. This may indicate that the value of acute phase SAA might reflect the severity of acute myocardial disorder. This notion was also supported by SAA in the acute phase having a positive correlation with the peak CK, which was thought to reflect the size of the infarct in MI.
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The exact mechanism for the association between inflammation and future cardiovascular risk is not known. Laboratory studies have demonstrated that inflammation plays a pathophysiological role in atherogenesis and may promote the development of atherosclerotic plaques in coronary arteries. Acute phase reactants may play a pathophysiological role in atherosclerotic plaque instability as manifested by elevated high-sensitivity CRP levels in the presence of ruptured coronary artery plaques. Like hs-CRP, SAA is synthesized in the liver in response to infection and inflammation. Accordingly, SAA is also a representative inflammatory reactant. It was reported that in AMI the inflammatory cytokine IL-6 and the acute phase reactant SAA were produced at the site of coronary occlusion by macrophages and possibly vascular cells, whereas CRP was produced mainly in the liver and was taken up locally by phagocyting white blood cells.
26) It was also reported that during the acute phase reaction, SAA was secreted as the predominant apolipoprotein on plasma HDL cholesterol particles. 27) These observations may explain its increased concentration in patients with ACS. Accordingly, SAA may be a more sensitive marker of severity of myocardial damage and may represent a different type of acute phase response than CRP.
Left ventricular systolic function in AMI patients is under the influence of the patency of the culprit coronary artery. On the other hand, an anterior myocardial infarction with left anterior descending coronary artery disease is evaluated most accurately by left venticulography with right-anterior deviation. For this reason, we analyzed 225 patients with anterior infarction and escape from reocclusion or restenosis of the culprit coronary artery. As a result, within the limits of these patients, SAA was slightly negatively correlated with LVEF in the chronic phase (r = -0.50, P = 0.06). The reason is believed to be the limited number of patients. We intend to examine this in a future study.
The results of the current study indicated significant positive correlations between the level of SAA in acute phase AMI and the levels of highly-sensitive CRP and peak CK. The peak CK level was considered to reflect infarct size. As previously noted, the peak CRP level was also associated with the severity of myocardial damage. These factors are also known to be predictors of left ventricular systolic dysfunction. Therefore, the SAA level in the acute phase of AMI may predict subsequent LV systolic dysfunction. Study limitations: This study has the following limitations. First, the small size of the sample population means that the results require confirmation in a largescale trial before any concrete significance can be extrapolated from them. Second, we excluded patients with renal failure on the basis that these patients were not able to tolerate coronary angioplasty. This may have introduced bias into the results. Third, patients who died within 24 hours of the onset of symptoms of AMI were also excluded since blood samples could not obtained at this point as stipulated by the protocol. This also may have been a source of bias. Fourth, the follow-up was as short as 6 months after onset, thereby not permitting us to obtain a long-term prognosis. Fifth, both anterior and inferior wall infarctions were mixed in the evaluation of cardiac function. Sixth, the SAA levels were assayed only at a single point. As pointed out above, the present study may not be satisfactory with respect to the number of patients and observation period, and therefore, more patients will be recruited for future study, with a long-term prognosis study being conducted. Conclusion : We have shown that acute phase plasma SAA concentrations after successful direct PCI in AMI patients are closely related to subsequent left-ventricular systolic dysfunction.
